rs763441792
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001160148.2(DDHD1):c.2276G>A(p.Gly759Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000589 in 1,613,852 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001160148.2 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hereditary spastic paraplegia 28Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DDHD1 | NM_001160148.2 | c.2276G>A | p.Gly759Glu | missense_variant | Exon 11 of 13 | ENST00000673822.2 | NP_001153620.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DDHD1 | ENST00000673822.2 | c.2276G>A | p.Gly759Glu | missense_variant | Exon 11 of 13 | NM_001160148.2 | ENSP00000500986.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152100Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251396 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461752Hom.: 0 Cov.: 30 AF XY: 0.0000536 AC XY: 39AN XY: 727164 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74308 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2276G>A (p.G759E) alteration is located in exon 11 (coding exon 11) of the DDHD1 gene. This alteration results from a G to A substitution at nucleotide position 2276, causing the glycine (G) at amino acid position 759 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Hereditary spastic paraplegia 28 Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 766 of the DDHD1 protein (p.Gly766Glu). This variant is present in population databases (rs763441792, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with DDHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 573202). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at